
Tata Motors Down by 5.93% at ₹615.15: Here is the Impact of CLSA Downgrade!
Updated: 22 Jul 2025 • 6:08 am
Posted by:

Tata Motors Limited, a passenger and commercial vehicle manufacturer, is now removed from the brokerage firm CLSA’s high-conviction outperform list. Currently, on 4th April (12:30 PM), the Tata Motors share is down by 5.93% and trading at ₹615.15.
The latest dip comes amidst news of CLSA’s downgrade of share ratings and cut in price targets. In the previous session on 3rd April 2025, investors’ reactions were attributed to the effect of reciprocal tariffs for car imports in the United States. But today is the second consecutive day when Tata Motors share has opened below its previous closing price.
CLSA mentioned in its note that the imposition of 25% import tariffs by US President Donald Trump and discontinuation of Jaguar Models would result in a 14% YoY decline in the JLR volumes. As a result, the EBIT margins of Tata Motors Limited will likely to be down 7% in the FY26- 27.
Moreover, CLSA has also reduced JLR’s (Jaguar Land Rover) target enterprise value-to-EBITDA multiple from 2.5 times to 2 times. Near-term growth challenges may bring this decline in JLR’s financial performance.
Tata Motors’ share opened with a dip of 1.81% on 3rd April against its closing price of ₹672.20 on 2nd April 2025. And today, the share is opened 0.84% down from its previous closing price. It remains to be seen how the stock holds up by the closing time!
Tata Motors Share Ratings
Out of 30 Analysts having coverage on Tata Motors Limited, 17 of them gave “Buy” ratings, but 6 of them have a “hold,” and 2 suggested to “sell” the share.
Check out our in-depth market news and get real-time stock market updates on Univest!
Read Other News Articles
Stocks to Watch Today, 3rd April 2025: GEPIL, HINDCOPPER, MARUTI, KIRLOSENG, and More!
Sensex/Nifty Live Updates 4th April 2025: Nifty Tumbles Over 1.21% and Sensex Fell By 700+ Points!
Recent Articles

Tera Software Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
9 July 2026

Artson Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
9 July 2026

Chandan Healthcare Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
9 July 2026

DIC India Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
9 July 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Tera Software Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Artson Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Chandan Healthcare Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
DIC India Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Glottis Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Popular this week
Tera Software Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Artson Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Chandan Healthcare Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
DIC India Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Glottis Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





